In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Infinity Reacquires Worldwide Rights to Its Hsp90 Inhibitor Program
INFINITY ANNOUNCES SMALL MOLECULE COLLABORATION WITH NOVARTIS
Infinity selects Evotec as partner
Curis Announces Collaborative Agreement between Genentech and National Cancer Institute on GDC-0449
Curis Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications
Curis Announces Conclusion of Hedgehog Agonist Collaboration with Wyeth
Curis Announces Collaborator Genentech's License of Ex-U.S. Rights to GDC-0449 to Roche
7TM Pharma signs research agreement with AstraZeneca
Vernalis signs research agreement with AstraZeneca
AstraZeneca and MedPointe establish U.S. partnering arrangement for Zomig(R)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
